Abstract
Three novel stable Pt(III) complexes with distorted octahedral structure and
Three novel stable Pt(III) complexes with distorted octahedral structure and
B. Rosenberg, “Platinum complexes for the treatment of cancer: why the search goes on?,” in Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, B. Lippert, Ed., pp. 3–27, Wiley-VCH, Zürich, Switzerland, 1999.
View at: Google ScholarJ. Reedijk, “Improved understanding in platinum antitumour chemistry,” Chemical Communications, no. 7, pp. 801–806, 1996.
View at: Publisher Site | Google ScholarE. R. Jamieson and S. J. Lippard, “Structure, recognition, and processing of cisplatin-DNA adducts,” Chemical Reviews, vol. 99, no. 9, pp. 2467–2498, 1999.
View at: Publisher Site | Google ScholarV. Barbec and J. Kasparkova, “DNA interactions of platinum anticancer drugs. Recent advances and mechanisms of action,” in Metal Compounds in Cancer Chemotherapy, J. M. Pérez, M. A. Fuertes, and C. Alonso, Eds., pp. 187–218, Research Signpost, Kerala, India, 2005.
View at: Google ScholarE. Wong and Ch. M. Giandomenico, “Current status of platinum-based antitumor drugs,” Chemical Reviews, vol. 99, no. 9, pp. 2451–2466, 1999.
View at: Publisher Site | Google ScholarV. Brabec and J. Kasparkova, “Platinum-based drugs,” in Metallotherapeutic Drugs & Metal-Based Diagnostic Agents, M. Gielen and Ed. Tiekink, Eds., pp. 489–506, John Wiley & Sons, London, UK, 2005.
View at: Google ScholarJ. Reedijk, “Why does cisplatin reach Guanine-N7 with competing S-donor ligands available in the cell?,” Chemical Reviews, vol. 99, no. 9, pp. 2499–2510, 1999.
View at: Publisher Site | Google ScholarB. P. Espósito and R. Najjar, “Interactions of antitumoral platinum-group metallodrugs with albumin,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 137–149, 2002.
View at: Publisher Site | Google ScholarV. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Pérez, “Is cisplatin-induced cell death always produced by apoptosis?,” Molecular Pharmacology, vol. 59, no. 4, pp. 657–663, 2001.
View at: Google ScholarM. A. Fuertes, J. Castilla, C. Alonso, and J. M. Pérez, “Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways,” Current Medicinal Chemistry, vol. 10, no. 3, pp. 257–266, 2003.
View at: Google ScholarC. J. Ziegler, A. P. Silverman, and S. J. Lippard, “High-throughput synthesis and screening of platinum drug candidates,” Journal of Biological Inorganic Chemistry, vol. 5, no. 6, pp. 774–783, 2000.
View at: Publisher Site | Google ScholarV. Brabec and J. Kasparkova, “Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs,” Drug Resistance Updates, vol. 8, no. 3, pp. 131–146, 2005.
View at: Publisher Site | Google ScholarD. Lebwohl and R. Canetta, “Clinical development of platinum complexes in cancer therapy: an historical perspective and an update,” European Journal of Cancer, vol. 34, no. 10, pp. 1522–1534, 1998.
View at: Publisher Site | Google ScholarCh.-H. Choi, Y.-J. Cha, and Ch.-S. An et al., “Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein,” Cancer Cell International, vol. 4, p. 6, 2004.
View at: Publisher Site | Google ScholarM. J. Cleare and J. D. Hoeschele, “Studies on the antitumor activity of group VIII transition metal complexes—part I. Platinum (II) complexes,” Bioinorganic Chemistry, vol. 2, no. 3, pp. 187–210, 1973.
View at: Publisher Site | Google ScholarJ. Reedijk, “Medicinal applications of heavy-metal compound,” Current Opinion in Chemical Biology, vol. 3, no. 2, pp. 236–240, 1999.
View at: Publisher Site | Google ScholarCh. X. Zhang and S. J. Lippard, “New metal complexes as potential therapeutics,” Current Opinion in Chemical Biology, vol. 7, no. 4, pp. 481–489, 2003.
View at: Publisher Site | Google ScholarM. D. Hall and T. W. Hambley, “Platinum(IV) antitumour compounds: their bioinorganic chemistry,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 49–67, 2002.
View at: Publisher Site | Google ScholarR. W. Boyle and D. Dolphin, “Structure and biodistribution relationships of photodynamic sensitizers,” Photochemistry and Photobiology, vol. 64, no. 3, pp. 469–485, 1996.
View at: Google ScholarR. Pottier and J. C. Kennedy, “The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue,” Journal of Photochemistry and Photobiology B: Biology, vol. 8, no. 1, pp. 1–16, 1990.
View at: Publisher Site | Google ScholarH. Brunner, M. R. Arndt, and B. Treittinger, “Porphyrin platinum conjugates—new aims,” Inorganica Chimica Acta, vol. 357, no. 6, pp. 1649–1669, 2004.
View at: Publisher Site | Google ScholarH. Ali and J. E. van Lier, “Metal complexes as photo- and radiosensitizers,” Chemical Reviews, vol. 99, no. 9, pp. 2379–2450, 1999.
View at: Publisher Site | Google ScholarA. Zajac, Zd. Jankiewicz, M. Skórczakowski, W. Zendzian, and G. A. Skripko, “Laser radiation sources applied to HpD diagnosis and therapy,” in Laser Technology V: Applications in Medicine and Ecology, vol. 3188 of Proceedings of SPIE, pp. 16–33, Szczecin-Swinoujscie, Poland, September 1996.
View at: Publisher Site | Google ScholarJ. P. Macquet, M. M. Millard, and T. Theophanides, “X-ray photoelectron spectroscopy of porphyrins,” Journal of the American Chemical Society, vol. 100, no. 15, pp. 4741–4746, 1978.
View at: Publisher Site | Google ScholarH. Kunkely and A. Vogler, “Photoreactivity of hematoporphyrin IX-dichloroplatinum(II). Light-induced release and activation of free base hematoporphyrin,” Inorganica Chimica Acta, vol. 254, no. 2, pp. 417–419, 1997.
View at: Publisher Site | Google ScholarH. Brunner, K.-M. Schellerer, and B. Treittinger, “Synthesis and in vitro testing of hematoporphyrin type ligands in platinum(II) complexes as potent cytostatic and phototoxic antitumor agents,” Inorganica Chimica Acta, vol. 264, no. 1-2, pp. 67–79, 1997.
View at: Publisher Site | Google ScholarCh. Lottner, K.-Ch. Bart, G. Bernhardt, and H. Brunner, “Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity,” Journal of Medicinal Chemistry, vol. 45, no. 10, pp. 2064–2078, 2002.
View at: Publisher Site | Google ScholarCh. Lottner, R. Knuechel, G. Bernhardt, and H. Brunner, “Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells,” Cancer Letters, vol. 215, no. 2, pp. 167–177, 2004.
View at: Publisher Site | Google ScholarP. R. Bontchev, M. Mitewa, and G. Gencheva, “New platinum(lI) and platinum(lll) complexes of creatinine,” Pure & Applied Chemistry, vol. 61, no. 5, pp. 897–902, 1989.
View at: Google ScholarG. Gencheva, M. Mitewa, and P. R. Bontchev, “Dimeric and oligomeric platinum(II, II), (II, III) and palladium(II, II) complexes with creatinine,” Polyhedron, vol. 11, no. 18, pp. 2357–2361, 1992.
View at: Publisher Site | Google ScholarM. Mitewa and G. Gencheva, “Platinum(III) formation and stabilization as “Platinum blues” with different types of ligands in the course of their interaction with – and cis-Pt,” Research on Chemical Intermediates, vol. 18, no. 2-3, pp. 115–129, 1992.
View at: Google ScholarM. Mitewa, G. Gencheva, and M. Mechkova, ““Platinum blue” complex with a new type of bridging ligand,” Journal of Inorganic Biochemistry, vol. 53, no. 2, pp. 151–156, 1994.
View at: Publisher Site | Google ScholarG. Gencheva, M. Mitewa, G. Gochev, I. Wawer, and V. Enchev, “Synthesis and structure of a new dimeric Pt(II)-Pt(III) complex with o-phthalic acid,” Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, vol. 28, no. 4, pp. 515–527, 1998.
View at: Google ScholarM. Mitewa, G. Gencheva, Sv. Bobev, G. Gochev, D. Mehandjiev, and I. Wawer, “Formation and stabilization of monomeric PT(III) species through complexation with linear tetrapyrrole ligand bilirubin,” Research on Chemical Intermediates, vol. 25, no. 5, pp. 431–439, 1999.
View at: Google ScholarJ. P. Davidson, P. J. Faber, and R. G. Fischer Jr. et al., ““Platinum pyrimidine blues” and related complexes: a new class of potent antitumor agents,” Cancer Chemotherapy Report, vol. 59, no. 2, part 1, pp. 287–300, 1975.
View at: Google ScholarT. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983.
View at: Publisher Site | Google ScholarS. M. Konstantinov, H. Eibl, and M. R. Berger, “BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines,” British Journal of Haematology, vol. 107, no. 2, pp. 365–374, 1999.
View at: Publisher Site | Google ScholarM. Inamo, N. Kamiya, Y. Inada, M. Nomura, and Sh. Funahashi, “Structural characterization and formation kinetics of sitting-atop (SAT) complexes of some porphyrins with copper(II) ion in aqueous acetonitrile relevant to porphyrin metalation mechanism. Structures of aquacopper(II) and Cu(II)-SAT complexes as determined by XAFS spectroscopy,” Inorganic Chemistry, vol. 40, no. 22, pp. 5636–5644, 2001.
View at: Publisher Site | Google ScholarG. Gencheva, D. Tsekova, G. Gochev, D. Mehandjiev, and P. R. Bontchev, “Monomeric Au(II) complex with hematoporphyrin IX,” Inorganic Chemistry Communications, vol. 6, no. 3, pp. 325–328, 2003.
View at: Publisher Site | Google ScholarK. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds—Part B, John Wiley & Sons, New York, NY, USA, 5th edition, 1997.
View at: Google ScholarC. C. Uphoff, S. Habig, S. Fombonne, Y. Matsuo, and H. G. Drexler, “ABL-BCR expression in BCR-ABL-positive human leukemia cell lines,” Leukemia Research, vol. 23, no. 11, pp. 1055–1060, 1999.
View at: Publisher Site | Google ScholarB. Desoize and C. Madoulet, “Particular aspects of platinum compounds used at present in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 317–325, 2002.
View at: Publisher Site | Google Scholar